Brought to you by 
VisionCare Ophthalmic Technologies closes its $31mm Series E round
03 Feb 2012
Executive Summary
VisionCare Ophthalmic Technologies Inc. (implantable ophthalmic devices) has raised $31mm through its Series E venture round. Saints Capital led and was joined by current shareholders Pitango Venture Capital, Three Arch Partners, Onset Ventures, and Newbury Acquisitions Fund/Infinity CSVC Management, and new backers Giza Ventures (which contributes a board member), General I Financial Holdings, and BSI SA. VisionCare will use the funds to launch its telescope prosthesis for end-stage AMD, for sales and marketing, and to continue developing new visual prosthetic devices for retinal disorders.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
VisionCare Ophthalmic Technologies closes its $31mm Series E round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice